Estrogen Deficiency
📧 Sign up to get email alerts when something new happens for Estrogen Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) [Phase 3]
A Phase 3 clinical trial (ESTIME) evaluating estradiol and testosterone subdermal implants for menopause treatment is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study) [Phase 4]
Phase 4 clinical trial (NoMEN Study) evaluating ovarian hormone regulation of central and cerebrovascular hemodynamics. The study is current…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women [Phase 2]
Phase 2 clinical trial update from Cedars-Sinai examining the interplay between atherosclerosis, immune-mediated inflammation, and hypoestro…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome [Phase 4]
Phase 4 clinical trial at Aarhus University Hospital is evaluating dose equivalence between oral and transdermal estradiol in women with Tur…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Cardiometabolic Consequences of the Loss of Ovarian Function [Phase 4]
A Phase 4 clinical trial from the University of Colorado, Denver is currently recruiting to evaluate cardiometabolic consequences of the los…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-06FDA Approved: ESTRADIOL — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original application for a generic Estradiol product.
-
FDA approval · 2019-05-03FDA Approved: DEPO-ESTRADIOL — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for Depo-Estradiol (estradiol cypionate) by Pharmacia & Upjohn Company LLC under ANDA085470.
-
FDA approval · 2008-10-30FDA Approved: EVAMIST — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for EVAMIST, a transdermal estradiol product, under Padagis US LLC.